MedTrace Logo

Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

NCT03517358 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-07-31

No results posted yet for this study

Summary

This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.

Conditions

Interventions

OTHER

Service of care

Subjects will be receiving care from case management or clinical pharmacy.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-05-01
Completion
2018-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03517358 on ClinicalTrials.gov